N端组氨酸SUMO/C-Strep重组尼帕病毒(NiV)核蛋白N蛋白
N端组氨酸SUMO/C-Strep重组尼帕病毒(NiV)核蛋白N蛋白，Recombinant Nipah virus/NiV Protein N/Nucleoprotein Protein, N-His-SUMO & C-Strep，非常适合开展WB，免疫，ELISA，SDS-PAGE和生物活性等应用类型。更多视频请关注视频号【艾维缔】。哔哩哔哩【IVDSHOW】。抖音【军哥聊表观】。
关键词
N端组氨酸SUMO/C-Strep重组尼帕病毒(NiV)核蛋白N蛋白
所属分类
目录号
YVV16602
- 产品描述
- 产品组分
- 文件资源
- 营销中心
- 注意事项
- FAQ
- 文献追踪
-
Expression system
E. coli
Species
Nipah virus (NiV)
Protein length
Thr32-Gly402
Predicted molecular weight
54.71 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Nucleoprotein, Protein N, Nucleocapsid protein, N
-
产品组分
内容
型号
规格 储存温度
N端组氨酸SUMO/C-Strep重组尼帕病毒(NiV)融合糖蛋白F0蛋白
YVV08101-01 100ug
-80°C N端组氨酸SUMO/C-Strep重组尼帕病毒(NiV)融合糖蛋白F0蛋白
YVV08101-02 1mg
-80°C 操作手册
1 1 常温
-
营销中心
-
注意事项
保存建议 厂家推荐蓝冰运输。当您收到产品后，按照说明书建议保存于-20°C。 -
FAQ
-
Cell-Free Expression of Nipah Virus Transmembrane Proteins for Proteoliposome Vaccine Design., PMID:40458951
An Intein-Spliced Nipah G Protein Ferritin Nanoparticle Vaccine Provides Complete Protection against Lethal Nipah Virus Challenge., PMID:40455749
Comprehensive immunoinformatics and bioinformatics strategies for designing a multi-epitope based vaccine targeting structural proteins of Nipah virus., PMID:40433372
Construction of Minigenome Replicon of Nipah Virus and Investigation of Biological Activity., PMID:40431718
A deep learning and molecular modeling approach to repurposing Cangrelor as a potential inhibitor of Nipah virus., PMID:40355437
The rising threat of Nipah virus: a highly contagious and deadly zoonotic pathogen., PMID:40349023
Machine learning assisted in Silico discovery and optimization of small molecule inhibitors targeting the Nipah virus glycoprotein., PMID:40341732
Design and Preliminary Immunogenicity Evaluation of Nipah Virus Glycoprotein G Epitope-Based Peptide Vaccine in Mice., PMID:40333318
Ephrin B1 and B2 Mediate Cedar Virus Entry into Egyptian Fruit Bat Cells., PMID:40285015
Implementation of RT-RAA and CRISPR/Cas13a for an NiV Point-of-Care Test: A Promising Tool for Disease Control., PMID:40284926
Viral Fragments in the Urine Proteome: New Clues to the Cause of Fever., PMID:40282183
Computational exploration of viral cell membrane structures for identifying novel therapeutic target., PMID:40175045
Evolutionary trajectories of Nipah virus: Evaluating the antiviral efficacy of Kabasura Kudineer Chooranam., PMID:40174499
Functional and antigenic landscape of the Nipah virus receptor-binding protein., PMID:40132580
Multi-platform omics analysis of Nipah virus infection reveals viral glycoprotein modulation of mitochondria., PMID:40106432
A conserved motif in Henipavirus P/V/W proteins drives the fibrillation of the W protein from Hendra virus., PMID:40100133
Cross-protectivity of henipavirus soluble glycoprotein in an in vivo model of Nipah virus disease., PMID:40078997
Investigating small molecules in propolis as Nipah virus glycoprotein (NiV-G) inhibitors through molecular interaction studies., PMID:40051842
Structural basis of Nipah virus RNA synthesis., PMID:40050611
Serological and molecular analysis of henipavirus infections in synanthropic fruit bat and rodent populations in the Centre and North regions of Cameroon (2018-2020)., PMID:39994638
Molecular modelling of 6-oxo-5-Sulfanyl-1H-Pyridine-3-Carboxylic acid and its adsorption with the silver complex: Structural, optical, charge transference, dynamics and docking to nipah virus., PMID:39965270
Cryo-EM structures of Nipah virus polymerase complex reveal highly varied interactions between L and P proteins among paramyxoviruses., PMID:39964914
Identification of potential therapeutic phytocompounds targeting the G-glycoprotein of Nipah Virus: an in-silico study., PMID:39876783
Development of nebulized inhalation delivery for fusion-inhibitory lipopeptides to protect non-human primates against Nipah-Bangladesh infection., PMID:39870114
Risk of Nipah Virus Seroprevalence in Healthcare Workers: A Systematic Review with Meta-Analysis., PMID:39861870
Molecular modelling and optimization of a high-affinity nanobody targeting the nipah virus fusion protein through in silico site-directed mutagenesis., PMID:39848170
Structural and functional analysis of the Nipah virus polymerase complex., PMID:39837328
Identification of CD8+ Immunogenic Peptides for Vaccine Design against Nipah Virus in Humans., PMID:39759209
Malaysia outbreak survivors retain detectable Nipah antibodies and memory B cells after 25 years., PMID:39755279
The nanoscale organization of the Nipah virus fusion protein informs new membrane fusion mechanisms., PMID:39745781
Structure of the Nipah virus polymerase complex., PMID:39739115
Clinical advancements in mRNA vaccines against viral infections., PMID:39734036
Integrated computational biophysics approach for drug discovery against Nipah virus., PMID:39729673
Alternative splicing expands the antiviral IFITM repertoire in Chinese rufous horseshoe bats., PMID:39724110
In silico identification of Nipah virus protein inhibitors from secondary metabolites of medicinal plants using a high-throughput virtual screening approach., PMID:39714114
Structural and antigenic characterization of novel and diverse Henipavirus glycoproteins., PMID:39713338
Functional assessment of the glycoproteins of a novel Hendra virus variant reveals contrasting fusogenic capacities of the receptor-binding and fusion glycoproteins., PMID:39704501
Cryo-EM structure of Nipah virus RNA polymerase complex., PMID:39661676
The E3 ligase RAD18-mediated ubiquitination of henipavirus matrix protein promotes its nuclear-cytoplasmic trafficking and viral egress., PMID:39628457
Cryo-EM structure of Nipah virus L-P polymerase complex., PMID:39627254
Therapeutics for Nipah virus disease: a systematic review to support prioritisation of drug candidates for clinical trials., PMID:39549708
Developing a chimeric multiepitope vaccine against Nipah virus (NiV) through immunoinformatics, molecular docking and dynamic simulation approaches., PMID:39521154
Recent report on indoles as a privileged anti-viral scaffold in drug discovery., PMID:39509946
An emerging zoonotic disease to be concerned about - a review of the nipah virus., PMID:39468679
Organotypic brain slices as a model to study the neurotropism of the highly pathogenic Nipah and Ebola viruses., PMID:39466030
Role of RNA G-Quadruplexes in the Japanese Encephalitis Virus Genome and Their Recognition as Prospective Antiviral Targets., PMID:39436355
Abortive infection of bat fibroblasts with SARS-CoV-2., PMID:39401365
How a paramyxovirus fusion/entry complex adapts to escape a neutralizing antibody., PMID:39396053
Structure of the Nipah virus polymerase phosphoprotein complex., PMID:39375338
Tetracistronic minigenomes elucidate a functional promoter for Ghana virus and unveils Cedar virus replicase promiscuity for all henipaviruses., PMID:39345144
在线留言
如果您对我们的产品感兴趣，请留下您的信息，我们将尽快与您联系，谢谢！
艾维缔官网
艾德官网
B站IVDSHOW
抖音军哥聊表观
视频号艾维缔
小红书艾维缔
快手表观盒子
表观遗传学
联系我们
